Spin-offs from our lab
Our research group has fostered several spin-offs that are now successfully translating our research into real-world applications.
Find out more below!
Seamless Therapeutics GmbH
Seamless Therapeutics pioneers gene-editing therapies through a unique approach that reprograms recombinases to address severe diseases with high precision. Their platform aims to broaden gene-editing applications, creating disease-modifying treatments for various health conditions.
PROVIREX Genome Editing Therapies GmbH
Provirex develops advanced gene-editing therapies focused on curing persistent viral infections. This technology utilizes highly precise recombinases to remove integrated viral genomes, such as HIV, from host cells without errors.
Eupheria Biotech GmbH
Eupheria Biotech develops and markets highly efficient and specific esiRNA technologies for precise gene silencing in research and therapeutic contexts, minimizing unintended effects and toxicity.